Q3 2019 Holdings
Filed 2019-11-14 | 58 holdings | $21.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celgene Corp(CELG) | COM | 151020104 | $17.0K | 171,022 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $20.0K | 316,284 | 0.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.2M | 36,500 | 5.6% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $1.3M | 13,800 | 6.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.4M | 68,000 | 11.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $2.7M | 33,800 | 12.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.9M | 87,284 | 27.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.4M | 31,700 | 34.9% |